| Literature DB >> 28328014 |
Alen Sevšek1, Luka Šrot1, Jakob Rihter1, Maša Čelan1, Linda Quarles van Ufford1, Ed E Moret1, Nathaniel I Martin1, Roland J Pieters1.
Abstract
A series of lipidated guanidino and urea derivatives of 1,5-dideoxy-1,5-imino-d-xylitol were prepared from d-xylose using a concise synthetic protocol. Inhibition assays with a panel of glycosidases revealed that the guanidino analogues display potent inhibition against human recombinant β-glucocerebrosidase with IC50 values in the low nanomolar range. Related urea analogues of 1,5-dideoxy-1,5-imino-d-xylitol were also synthesized and evaluated in the same fashion and found to be selective for β-galactosidase from bovine liver. No inhibition of human recombinant β-glucocerebrosidase was observed for the urea analogues. Computational studies provided insight into the potent activity of analogues bearing the substituted guanidine moiety in the inhibition of lysosomal glucocerebrosidase (GBA).Entities:
Keywords: Gaucher disease; glycosidase inhibitors; guanidinium; iminosugars; pharmacological chaperones; β-glucocerebrosidase
Mesh:
Substances:
Year: 2017 PMID: 28328014 DOI: 10.1002/cmdc.201700050
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466